TP53 and cancer: To further investigate the discrepancy involving the Y234H variant, we evaluated the TP53 locus in our LNCaP_FGC cells using a capture-based sequencing platform, UW-OncoPlex, designed to assess the mutation and copy-number status of 400 cancer-associated genes (44).